BIOCHEMICAL PORTRAYAL of DIFFERENT BITTER GOURD (Momordica Charantia L.) CULTIVARS with SPECIAL REFERENCE to THEIR THERAPEUTIC POTENTIAL

Total Page:16

File Type:pdf, Size:1020Kb

BIOCHEMICAL PORTRAYAL of DIFFERENT BITTER GOURD (Momordica Charantia L.) CULTIVARS with SPECIAL REFERENCE to THEIR THERAPEUTIC POTENTIAL BIOCHEMICAL PORTRAYAL OF DIFFERENT BITTER GOURD (Momordica charantia L.) CULTIVARS WITH SPECIAL REFERENCE TO THEIR THERAPEUTIC POTENTIAL By Mahwish 2006-GCUF-557-524 A thesis submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY IN FOOD & NUTRITION DEPARTMENT OF FOOD SCIENCE, NUTRITION & HOME ECONOMICS INSTITUTE OF HOME & FOOD SCIENCES, GOVERNMENT COLLEGE UNIVERSITY, FAISALABAD. 2017 2 DEDICATED TO HOLY PROPHET MUHAMMAD (Peace be upon Him) & My Loving Family 3 DECLARATION The work reported in this thesis was carried out by me under the supervision of Dr. Farhan Saeed, Assistant Professor, Institute of Home & Food Sciences, GC University, Faisalabad, Pakistan. I hereby declare that the title of thesis, “BIOCHEMICAL PORTRAYAL OF DIFFERENT BITTER GOURD (Momordica charantia L.) CULTIVARS WITH SPECIAL REFERENCE TO THEIR THERAPEUTIC POTENTIAL” and the contents of this thesis are the product of my own research and no part has been copied from any published source (expect the references, standard mathematical or genetic models / equations / formulas / protocols etc.). I, further, declare that this work has not been submitted for the award of any other diploma/degree. The university may take action if the information provided found inaccurate at any stage. Mahwish 2006-GCUF-557-524 4 5 CONTENTS Sr. No. Title Page # 1 INTRODUCTION 1 2 REVIEW OF LITERATURE 6 3 MATERIALS AND METHODS 27 4 RESULTS AND DISCUSSION 44 5 SUMMARY 162 6 REFERENCES 169 6 LIST OF CONTENTS Acknowledgments Abstract 1. INTRODUCTION 1 2. REVIEW OF LITERATURE 6 2.1. Concept of functional and nutraceutical foods 6 2.2. Bitter gourd (Momordica charantia); an overview 7 2.3. Chemistry 9 2.3.1. Chemical composition and Mineral analysis 9 2.3.2. Ascorbic acid contents 11 2.4. Bitter gourd-a source of natural antioxidants 11 2.5. Preparation of bitter gourd extract 16 2.6 Bioactive molecules in bitter gourd 16 2.6.1. Polypeptide-p 18 2.6.2. Charantin 18 2.6.3. Other bioactive molecules 18 2.7. Health claims of bitter gourd 19 2.7.1 Role of bitter gourd in diabetes mellitus 20 2.7.2 Lipid lowering potential of bitter gourd 23 3. MATERIALS AND METHODS 27 3.1. Procurement of raw material 27 3.2. Raw material handling 27 3.3. Chemical analysis of raw material 28 3.3.1. Moisture content 28 3.3.2. Ash content 28 3.3.3. Crude protein 29 3.3.4. Crude fat 29 3.3.5. Crude fiber 30 3.3.6. Nitrogen free extracts (NFE) 30 3.4. Minerals analysis 30 3.5. Quantification of Ascorbic acid 30 3.6. Preparation of extracts 31 3.7. Antioxidative profiling of bitter gourd extracts 31 3.7.1. Determination of total polyphenols 31 3.7.2. Determination of total flavonoid content 31 3.7.3. Free radical scavenging activity (DPPH assay) 32 3.7.4. Ferric reducing antioxidant power (FRAP) 32 3.7.5. β Carotene bleaching assay 33 3.7.6. ABTS assay 33 3.8. Bioactive compounds or phytochemicals 34 7 3.8.1. Total saponin contents 34 3.8.2. Charantin 34 3.8.3. Total alkaloid 35 3.8.4. Momordicin I & II 35 3.8.5. Vicine 36 3.8.6. Polypeptide P 36 3.9. Selection of best treatment 36 3.10. Product development (Functional drink) 36 3.11. Physicochemical assay of bitter gourd juice 37 3.11.1. Total soluble solids 37 3.11.2. pH 38 3.11.3. Acidity 38 3.11.4. Colour 38 3.11.5. Sensory evaluation 38 3.12. Bioevaluation studies 39 3.12.1. Study I: Rats fed with normal diet 39 3.12.2. Study II: Hyperglycemic rats 40 3.12.3. Study III: Hyperlipidemic rats 40 3.13. Feed plans for experimental rats 40 3.14. Feed and water intake 41 3.15. Body weight gain 41 3.16. Hypoglycemic perspectives 41 3.17. Serum lipid profile 42 3.17.1. Cholesterol 42 3.17.2. Low density & high density lipoproteins 42 3.17.3. Triglycerides 42 3.18. Liver functioning tests 42 3.19. Kidney functioning tests 42 3.20. Weight of body organ 43 3.21. Statistical analysis 43 4. RESULTS AND DISSCUSSION 44 4.1. Chemical composition 44 4.2. Macro and micro mineral analysis 52 4.3. Antioxidant indices of bitter gourd extracts 65 4.4. Phytochemical or bioactive molecules in bitter gourd 80 4.5. Product development 93 4.5.1. Physical attributes of bitter gourd functional drink 93 4.5.2. Sensory evaluation of bitter gourd functional drink 97 4.6. Bio-evaluation studies 105 4.6.1. Feed intake 105 4.6.2. Water intake 106 4.6.3. Body weight gain 112 4.6.4. Glucose 115 4.6.5. Insulin 120 8 4.6.6. Cholesterol 125 4.6.7. Low Density Lipoproteins (LDL) 130 4.6.8. High Density Lipoproteins (HDL) 131 4.6.9. Triglycerides 139 4.6.10. Alkaline phosphatase (ALP) 143 4.6.11. Alanine Transferase (ALT) 144 4.6.12. Aspartate Transferase (AST) 147 4.6.13. Serum creatinine 150 4.6.14. Serum urea 153 4.6.15. Effect on different organs 156 5. SUMMARY 162 CONCLUSIONS 167 RECOMMENDATIONS 168 REFERENCES 169 APPENDICES 200 9 LIST OF TABLES Sr. No Title Page # 3.1 Composition of different bitter gourd functional drinks (100g) 37 3.2 Diet plan used in the studies 41 4.1 Mean squares for proximate composition of different cultivars and parts 47 4.2 Mean values for moisture contents (%) in different cultivars and parts 47 4.3 Mean values for ash (%) in different cultivars and parts 48 4.4 Mean values for crude protein (%) in different cultivars and parts 48 4.5 Mean values for crude fat (%) in different cultivars and parts 51 4.6 Mean values for crude fiber (%) in different cultivars and parts 51 4.7 Mean values for crude NFE (%) in different cultivars and parts 53 Mean squares for macro and micro mineral analysis of different cultivars 4.8 56 and parts 4.9 Mean values for K (mg/100g) in different cultivars and parts 57 4.10 Mean values for P (mg/100g) in different cultivars and parts 57 4.11 Mean values for Mg (mg/100g) in different cultivars and parts 60 4.12 Mean values for Na (mg/100g) in different cultivars and parts 60 4.13 Mean values for Ca (mg/100g) in different cultivars and parts 61 4.14 Mean values for Fe (mg/100g) in different cultivars and parts 61 4.15 Mean values for Zn (mg/100g) in different cultivars and parts 64 4.16 Mean squares for antioxidant indices of different treatments and parts 66 Mean values for total phenolic contents (mg GAE/100g) of water and 4.17 67 methanolic extract of BG cultivars and parts Mean values for total flavonoid contents (mg RuE/100g) of water and 4.18 70 methanolic extract of BG cultivars and parts 10 Mean values for DPPH (%) assay of water and methanolic extract of BG 4.19 74 cultivars and parts Mean values for FRAP (μg FE/g) assay of water and methanolic extract 4.20 75 of BG cultivars and parts Mean values for β-carotene bleaching assay (%) of water and methanolic 4.21 78 extract of BG cultivars and parts Mean values for ABTS (μmol TE/g) assay of water and methanolic 4.22 79 extract of BG cultivars and parts 4.23 Mean square for Ascorbic acid in different cultivars and parts 81 4.24 Mean values for Ascorbic acid (mg/100g) in different cultivars and parts 81 Mean squares for total saponin and charantin in different cultivars and 4.25 84 parts 4.26 Mean values for total saponin (%) in different cultivars and parts 84 4.27 Mean values for charantin (mg/g) in different cultivars and parts 85 4.28 Mean squares for alkaloids in different cultivars and parts 87 4.29 Mean values for alkaloids (%) in different cultivars and parts 87 Mean squares for momordicin I, II & vicine in different cultivars and 4.30 88 parts 4.31 Mean values for Momordicine I (mg/100g) in different cultivars and parts 88 Mean values for Momordicine II (mg/100g) in different cultivars and 4.32 90 parts 4.33 Mean values for Vicine (μg/100μg) in different cultivars and parts 90 4.34 Mean square for Polypeptide P in different cultivars and parts 92 4.35 Mean values for Polypeptide P (mg/g) in different cultivars and parts 92 4.36 Mean squares for physical attributes of bitter gourd drink 94 4.37 Effect of treatments and storage on TSS of bitter gourd functional drink 94 4.38 Effect of treatments and storage on pH of bitter gourd functional drink 96 4.39 Effect of treatments and storage on acidity of bitter gourd functional drink 96 Effect of treatments and storage on L* value of bitter gourd functional 4.40 98 drink 11 Effect of treatments and storage on a* value of bitter gourd functional 4.41 98 drink Effect of treatments and storage on b* value of bitter gourd functional 4.42 99 drink 4.43 Mean squares showing treatments and storage effect on sensory attributes 101 4.44 Effect of treatments and storage on Colour scores of drink 101 4.45 Effect of treatments and storage on Aroma scores of drink 102 4.46 Effect of treatments and storage on Flavour scores of drink 102 4.47 Effect of treatments and storage on Taste scores of drink 103 4.48 Effect of treatments and storage on Overall acceptability scores of drink 103 4.49 Mean squares for effect of diet and study weeks on feed intake 107 4.50 Mean squares for effect of diet and study weeks on water intake 110 4.51 Mean squares for effect of diet and study weeks on body weight gain 113 4.52 Mean squares for effect of diet and study intervals on Glucose of rats 117 4.53 Effect of diet and study intervals on Glucose (mg/dL) 118 4.54 Mean squares for effect of diet and study intervals on Insulin of rats 122 4.55 Effect of diet and study intervals on Insulin (μIU/mL) 123 4.56 Mean squares for effect of diet and study intervals on Cholesterol of rats 127 4.57 Effect of diet and study intervals on Cholesterol (mg/dL) 128 4.58 Mean squares for effect of diet and study intervals on LDL of rats 132 4.59 Effect of diet and study intervals on LDL (mg/dL) 133 4.60 Mean squares for effect of diet and study
Recommended publications
  • The Use of Plants in the Traditional Management of Diabetes in Nigeria: Pharmacological and Toxicological Considerations
    Journal of Ethnopharmacology 155 (2014) 857–924 Contents lists available at ScienceDirect Journal of Ethnopharmacology journal homepage: www.elsevier.com/locate/jep Review The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations Udoamaka F. Ezuruike n, Jose M. Prieto 1 Center for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39 Brunswick Square, WC1N 1AX London, United Kingdom article info abstract Article history: Ethnopharmacological relevance: The prevalence of diabetes is on a steady increase worldwide and it is Received 15 November 2013 now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of Received in revised form herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby 26 May 2014 carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on Accepted 26 May 2014 the available evidence on the species' pharmacology and safety, we highlight ways in which their Available online 12 June 2014 therapeutic potential can be properly harnessed for possible integration into the country's healthcare Keywords: system. Diabetes Materials and methods: Ethnobotanical information was obtained from a literature search of electronic Nigeria databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants Ethnopharmacology used in diabetes management, in which the place of use and/or sample collection was identified as Herb–drug interactions Nigeria. ‘Diabetes’ and ‘Nigeria’ were used as keywords for the primary searches; and then ‘Plant name – WHO Traditional Medicine Strategy accepted or synonyms’, ‘Constituents’, ‘Drug interaction’ and/or ‘Toxicity’ for the secondary searches.
    [Show full text]
  • A Review on Biological Attributes of Momordica Charantia
    Advances in Bioscience and Bioengineering 2021; 9(1): 8-12 http://www.sciencepublishinggroup.com/j/abb doi: 10.11648/j.abb.20210901.12 ISSN: 2330-4154 (Print); ISSN: 2330-4162 (Online) Review Article A Review on Biological Attributes of Momordica charantia Zermina Khalid 1, Syeda Mona Hassan 1, Shahzad Sharif Mughal 1, *, Syed Khurram Hassan 2, Huma Hassan 3 1Department of Chemistry, Lahore Garrison University, Lahore, Pakistan 2Institute of Quality and Technology Management, University of the Punjab, Lahore, Pakistan 3Department of Chemical Engineering, NFC Institute of Engineering and Fertilizer Research, Faisalabad, Pakistan Email address: *Corresponding author To cite this article: Zermina Khalid, Syeda Mona Hassan, Shahzad Sharif Mughal, Syed Khurram Hassan, Huma Hassan. A Review on Biological Attributes of Momordica charantia . Advances in Bioscience and Bioengineering. Vol. 9, No. 1, 2021, pp. 8-12. doi: 10.11648/j.abb.20210901.12 Received : June 22, 2020; Accepted : November 2, 2020; Published : March 26, 2021 Abstract: Momordica charantia is an herbal climber grown in tropical and subtropical regions, belonging to the Cucurbitaceae family. M. charantia can be used as remedyagainst various diseases from ancient time. It has been used in various Asian traditional medicines for the treatment of cholera, bronchitis, anemia, blood diseases, ulcer, diarrhea, dysentery, gonorrhea rheumatism, gout, worms, colic, disease of liver and spleen, cancer and diabetes etc. The main constituents of M. charantia are triterpene, protein, steroid, alkaloid, inorganic, lipid, and phenolic compounds, which are responsible for biological and pharmacological activities including anti-diabetic, anti-cancerous and anti-tumorous, anti-microbial, anti-viral, anti-helmintic, antimalarial, anti-ulcerative and immunomodulatory.
    [Show full text]
  • International Journal of Ayurveda and Pharma Research
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by International Journal of Ayurveda and Pharma Research ISSN: 2322 - 0902 (P) ISSN: 2322 - 0910 (O) International Journal of Ayurveda and Pharma Research Review Article A REVIEW OF HYPOGLYCEMIC EFFECT OF MOMORDICA CHARANTIA W.S.R. TO MADHUMEH Bhageshwary Janagal1*, Chandan Singh2, Rajendra Prasad Purvia3, Manoj Adlakha3 *1MD Scholar, 2H.O.D.,3Assistant Professor, Dept. of Dravyaguna, Dr.S.R. RAU, Jodhpur, India. ABSTRACT Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both processes are involved in the development of diabetes. Diabetes is also known as Madhumeha in Ayurveda. Diabetes Mellitus has become a global problem in spite of advances in modern science. Ancient science of Ayurveda has discussed diabetes at length thousands of years ago. Number of diabetic patients are increasing in very high range. Year by year, its growing speed is very fast. In Ayurveda there are many ways to prevent diabetes mellitus and to cure its complications. Ayurvedic medications and management is very helpful and very effective in specially for diabetes. In this paper, trying to explain the hypoglycemic effect of Momordica (Karela) in diabetes mellitus (Madhumeh). Karela is specifically used as a folk medicine for diabetes. Several researches proved that it contains a hypoglycaemic or insulin-like principle, designated as 'plant-insulin', which has been found highly beneficial in lowering the blood and urine sugar levels. KEYWORDS: Karela, Momordica Charantia, Diabetes mellitus, Madhumeh, Ayurveda. INTRODUCTION Diabetes mellitus is considered as one of the Sedentary habits, consumes food and drinks which five leading causes of death in the world.
    [Show full text]
  • Momordica Charantia) Fruits As Ecofriendly Corrosion Inhibitor for Mild Steel in 1 M Hcl Solution
    Int. J. Electrochem. Sci., 14 (2019) 6814 – 6825, doi: 10.20964/2019.07.75 International Journal of ELECTROCHEMICAL SCIENCE www.electrochemsci.org Electrochemical Studies of Bitter Gourd (Momordica charantia) fruits as Ecofriendly Corrosion Inhibitor for Mild Steel in 1 M HCl Solution Aijuan Zhao1, Haijie Sun1,*, Lingxia Chen1, Yufang Huang1, Xingjie Lu2,*, Bing Mu1, Hairong Gao1, Shaoqing Wang1, Ambrish Singh3 1 Institute of Environmental and Catalytic Engineering, College of Chemistry and Chemical Engineering, Zhengzhou Normal University, Zhengzhou 450044, Henan, China. 2 Henan Institute of Metrology, Zhengzhou-450000, Henan, China. 3 School of Materials Science and Engineering, Southwest Petroleum University, Chengdu, Sichuan 610500, China. *E-mail: [email protected], [email protected] Received: 9 March 2019 / Accepted: 22 April 2019 / Published: 10 June 2019 Fruits extract of Momordica charantia (MCFE) was characterized using gas chromatography (GC), and mass spectrometry (MS) methods. The influence of MCFE on corrosion of mild steel in 1M HCl solution was evaluated using static electrochemical methods. Electrochemical Impedance Spectroscopy (EIS) and polarization studies were performed to derive the kinetic mechanism taking place at the electrodes. Micro-electrochemical tests were performed using scanning electrochemical microscopy (SECM) technique. The surface was further examined by scanning electron microscope (SEM). The EIS results suggested that the increase in the concentration of MCFE increased the inhibition efficiency. Polarization statistics pointed towards the changes in the anodic and cathodic kinetics, but overall shift of –Ecorr was less than 85 mV suggesting the MCFE inhibitor belongs to mixed type category. SEM studies revealed that the surface of the mild steel was quite unaffected with MCFE film on it in 1M HCl solution.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0271923 A1 Reid (43) Pub
    US 20140271923A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0271923 A1 Reid (43) Pub. Date: Sep. 18, 2014 (54) COMPOSITIONS & FORMULATIONS FOR (52) U.S. Cl. PREVENTING AND TREATING CHRONIC CPC ............. A6 IK3I/122 (2013.01); A61 K38/063 DISEASES THAT CLUSTER IN PATIENTS (2013.01); A61 K3I/496 (2013.01); A61 K SUCH AS CARDIOVASCULAR DISEASE, 45/06 (2013.01); A61 K31/4164 (2013.01); DLABETES, OBESITY, POLYCYSTIC OVARY A61K 31/12 (2013.01); A61 K3I/375 SYNDROME, HYPERLIPIDEMIA AND (2013.01); A61 K3I/355 (2013.01) HYPERTENSION, ASWELLAS FOR USPC ..... 424/651: 514/690: 514/21.9; 514/254.07; PREVENTING AND TREATING OTHER 514/383: 514/365: 514/256; 514/398: DISEASES AND CONDITIONS 514/236.2: 514/314: 514/154: 514/311; 514/31; 514/77; 514/39; 514/275; 514/253.08 (71) Applicant: Christopher Brian Reid, Los Angeles, CA (US) (57) ABSTRACT Patients inflicted with various clustering chronic diseases (72) Inventor: Christopher Brian Reid, Los Angeles, require treatment with multiple drugs having distinct mecha CA (US) nisms of action. Accordingly, patients with multiple condi tions suffer from cumulative side effects of multiple drugs as (21) Appl. No.: 13/815,664 well as drug-drug interactions. Embodiments, agents, com pounds or drugs of the present invention, such as sesquiter (22) Filed: Mar 14, 2013 penes, e.g., Zerumbone, replace an equal or larger number of approved drugs during patient treatment. Examples of disor Publication Classification ders prevented or ameliorated by administration of the for mulations of this invention include but are not limited to (51) Int.
    [Show full text]
  • Global Collaboration for Addressing Global Climate Change
    1/25/2019 Global Collaboration for Addressing Global Climate Change Chittaranjan Kole Raja Ramanna Fellow, Govt. of India ICAR-NRCPB, India 1 1/25/2019 Climate Change • Temp increased by 0.2-0.3°C during 1980 to 2000 • Temp to increase by 4°C by 2100 • Extreme temps, drought, flooding, salinity, input non-bioavailability, biotic stresses, GHG emission ……. • Expected reduction of yield of cereals: 10-15% 2 1/25/2019 Future Research Priorities • Genome designing for Climate Smart Agriculture • Harnessing agriculture for Health & Environment A Sweet Story with Bitter Melon as the Model • Popular vegetable ‘food crop’ • Contains anticancer & antidiabetic ‘bioactives’ • Produces large quantity of ‘biomass’ • Grown under ‘organic’ cultivation • Possesses ‘genome elasticity’ • A new crop for step-wise genome elucidation & improvement “Chitta, …. You should also do some works that will benefit people immediately.” New Crop - New Trait - New Strategy 3 1/25/2019 Phytomedicines in Bitter Melon (32) Alkaloids Galacturonic acids Lauric acid Charantin Gentisic acid Linoleic acid Linolenic β-Carotene Goyaglycosides acid Charine Goyasaponins Lycopene Cryptoxanthin Guanylate MAP-30 Cucurbitins Gyclase inhibitors Momorcharasides Cucurbitacins Gypsogenin Hydroxytryptamines Momorcharins Cycloartenols Karounidiols Momordenol Diosgenin Momordicilin Elaeostearic acids Lanosterol Momordicins Erythrodiol Momordicinin Bitter Melon as a Model Phytomedicines in Bitter Melon (31) Momordicosides Plant Insulin Trypsin inhibitors Momordin Family Cucurbitaceae Proteins
    [Show full text]
  • Karela, a Plant with Many Properties
    International Journal of Agriculture Innovations and Research Volume 3, Issue 1, ISSN (Online) 2319-1473 Manuscript Processing Details (dd/mm/yyyy) : Received : 11/06/2014 | Accepted on : 18/06/2014 | Published : 28/06/2014 Karela, a Plant with Many Properties Alireza Mobaraki Tayebeh Nakhaei Moghaddam Pharm. D., Deputy Director of Food & Drug, M.Sc. in Food Science and Technology, Supervising Food and Zahedan University of Medical Sciences, Zahedan, Iran Cosmetic Bachelor, Chabahar Healthcare Network, (Phone: +989126179000; Fax: +985413229787) Zahedan University of Medical Sciences, Zahedan, Iran Abstract – Karela is one of the most popular vegetables in sugar levels cannot solely be controlled through diet, tropical regions, particularly in Asia. This plant is grown for weight loss, exercise and oral medications, the primary the first time in the Kahiir vill, Konarak City, Sistan and treatment for patients with type 1 and also type 2 diabetes Baloochestan Province. Fruits are warty, sometimes smooth, is insulin. Diabetes mellitus cause metabolic disorders and yellowish green to dark green, when ripped it is yellow and hyperglycemia resulting from defects in insulin secretion, orange. This plant has lots of properties. Fruits are rich in polypeptide P, insulin and vegetables charantin, which insulin action or both (Celia et al, 2003). reduces blood sugar. Fruit and leaves contain Granulated that destroy cancer-causing substances chemically and slow II. KARELA FOOD AND MEDICINAL USE their activity. Oleic acid is the most sensible fatty acid found in Karela fruits; in addition, Karela fruit and seed can be Karela is generally used as food and medicine. Raw used traditionally as anti- HIV virus medicinal herb, ulcers, fruits are used as food, leaves and young stems are directly inflammations and tumors.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2007/014818.6 A1 Ketzis (43) Pub
    US 200701 481 86A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/014818.6 A1 Ketzis (43) Pub. Date: Jun. 28, 2007 (54) SIMAROUBA AMARA AND/OR (52) U.S. Cl. ........................................................ 424/195.11 MOMORDICA CHARANTIA EXTRACTS FOR THE TREATMENT OF COCCDIOSIS IN (57) ABSTRACT POULTRY Described is the use of a coccidiostatically effective amount (76) Inventor: Jennifer Ketzis, Ballina (IE) of Simarouba amara either alone or in combination with Momordica charantia for the manufacture of a medicament Correspondence Address: for the therapy of coccidiosis in poultry. Further described is NOVARTS a method for controlling coccidiosis in poultry based on the CORPORATE INTELLECTUAL PROPERTY administering of said medicament. Described is also a ONE HEALTH PLAZA 104/3 poultry feed supplement or medicated poultry feed for the EAST HANOVER, NJ 07936-1080 (US) control of coccidiosis in poultry that comprises besides ground dry vegetable- and/or animal-based poultry feed, (21) Appl. No.: 10/586,419 with or without additives such as proteins, vitamins and minerals, and a coccidiostatically effective amount of Sima (22) PCT Filed: Feb. 2, 2005 rouba amara dried bark or an extract thereof either alone or in combination with Momordica charantia fruit extract. Also (86). PCT No.: PCT/EP05/O1041 described is the production of said medicament and to the use of said active ingredients as an additive to dry or wet S 371(c)(1), poultry food or drinking water for the prophylactic or (2), (4) Date: Jul. 19, 2006 curative treatment of coccidial infections in poultry. Another (30) Foreign Application Priority Data described embodiment relates to the management for pre venting the development of resistant Eimeria strains that Feb.
    [Show full text]
  • Momordica Charantia Linn. (Karela): Nature's Silent Healer
    Volume 11, Issue 1, November – December 2011; Article-007 ISSN 0976 – 044X Review Article MOMORDICA CHARANTIA LINN. (KARELA): NATURE’S SILENT HEALER Madhu Gupta, Sushil Sharma, Ajay K. Gautam and Rekha Bhadauria* School of Studies in Botany, Jiwaji University Gwalior (M.P.) 474011, India. Accepted on: 21-07-2011; Finalized on: 20-10-2011. ABSTRACT Momordica charantia Linn. (karela) is an herbal climber grown in tropical and subtropical regions, belonging to the Cucurbitaceae family. Momordica charantia (Karela) have provided many remedies for various diseases from ancient days to now a day. It has been used in various Asian traditional medicines for the treatment of cholera, bronchitis, anemia, blood diseases, ulcer, diarrhea, dysentery, gonorrhea rheumatism, gout, worms, colic, disease of liver and spleen, cancer and diabetes etc. The main constituents of Karela are triterpene, protein, steroid, alkaloid, inorganic, lipid, and phenolic compounds, which are responsible for biological and pharmacological activities including anti-diabetic, anti-cancerous and anti-tumorous, anti-microbial, anti-viral, anti-helmintic, anti- malarial, anti-ulcerative and immunomodulatory. Combination of its Ayuervedic properties i.e. Gunna, Rasa and Virya (Dry, pungent, light, bitter and hot) makes it the real natures wonder. In this article, general description, traditional uses and medicinal properties of Momordica charantia Linn (Karela) have been reviewed. Keywords: Momordica charantia Linn. (karela), general description, medicinal properties. INTRODUCTION Cultivation Momordica charantia Linn. (Karela) commonly known as Karela is an annual or perennial climber found throughout Bitter melon or Bitter gourd is tropical and subtropical India and also cultivated up to an altitude of 1500m. It is climber of the family Cucurbitaceae.
    [Show full text]
  • Synthesis Calix[4]Resorcinarene from Cassia Oil
    Prosiding Seminar Kimia Bersama UKM-ITB VIII 9-11 Jun 2009 ANTIHYPERGLICEMIC EFFECT OF FLESHED AND SEEDED EXTRACT OF MOMORDICA CHARANTIA SITI AISYAH1*, HAYAT SHOLIHIN1, IQBAL MUSTHAPA1, ATUN QOWIYAH2 1Department of Chemistry Education, Faculty of Mathematics and Natural Sciences, Indonesia University of Education, Jl. Setiabudi 229 Bandung 2 Faculty of Pharmacy, University of Garut, Jl. Jati 42 Tarogong Garut *email: [email protected] ABSTRACT The research is conducted in order to discover active fraction toward the reduction of blood glucose (antihyperglicemic) from fleshed and seed of Momordica charantia or pare. Extraction is carried out using methanol solvent proceeded with fractionation using organic solvent such as hexane, ethyl acetate, and n-butanol. Entire extracts and fractions are examined to obtain the information of blood glucose intensity reduction activities and the major compound group characteristics with Liebermann- Burchad methods and FT-IR spectroscopy. Based on the glucose tolerance test with in vivo way on Wistar rats it is discovered that hexane fraction of the fleshed is the most active and the fraction insertion causes the mouse with lower blood glucose intensity differs significantly from the positive control. Based on the characteristic test with color method Lieberman-Burchad and spectroscopy IR, active fraction hexane is presumed to contain the major compound such as unglycosides terpenes. Keywords : antihyperglicemic, Momorica charantia, glucose tolerance test. INTRODUCTION Diabetes mellitus is the commonest endocrine disorder attacking more than 4% of people around the world. World Health Organization (WHO) assume that the disease will affect five times more people in th world (Grover, J.K., et al. 2002). The disease is indicated by the increase of blood glucose intensity.
    [Show full text]
  • New Aliphatic Alcohols from Seeds of Momordica Charantia Linn. and Prediction of Their Biological Activity
    Available online at www.derpharmachemica.com ISSN 0975-413X Der Pharma Chemica, 2018, 10(10): 1-25 CODEN (USA): PCHHAX (http://www.derpharmachemica.com/archive.html) New Aliphatic Alcohols from Seeds of Momordica charantia Linn. and Prediction of their Biological Activity Deepti Katiyar1*, Vijender Singh2, Mohammed Ali3 1Department of Pharmacognosy, KIET School of Pharmacy, Ghaziabad, UP, India 2School of Pharmacy, Sharda University, Greater Noida, UP, India 3Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India ABSTRACT Momordica charantia is a very well-known traditional medicinal herb. The current research investigation aimed towards the isolation, characterization and prediction of biological activity spectra of the phytoconstituents from the seeds of Momordica charantia Linn. (Cucurbitaceae). The Ethanolic extract of Momordica charantia seeds led to isolate two new aliphatic alcohols: n-nonatriacontan-19α-ol &n- henetetracontan-19α-ol and four known compounds: n-tetracosane, n-pentacosane, n-pentatriacontane, n-heptatriacontan-15α-ol. These isolated phytomolecules can act as the marker compounds in order to establish the identity, quality and purity of the drug. The observations of the in silico profiling of these compounds shall be very useful for the upcoming reaearchers for establishing them as pharmacologically active moieties. Keywords: n-nonatriacontan-19α-ol, n-henetetracontan-19α-ol, n-tetracosane, n-pentacosane, n-pentatriacontane, n-heptatriacontan-15α-ol. INTRODUCTION Momordica charantia Linn. (Family: Cucurbitaceae) is commonly known as karela in hindi; bitter gourd, bitter cucumber, bitter melon or balsam pear in English and karavella in Sanskrit [1]. It is a monoecious annual climber which grows upto 5 m in height cultivated in East Africa, South America, China, Malaya and India upto an altitude of 1500 m and it also grows wildely in tropical and sub-tropical Africa, Asia, America and Caribbean [2].
    [Show full text]
  • Research Paper Investigation of Antimicrobial Activity and Chemical
    Academia Journal of Medicinal Plants 6(7): 163-167, July 2018 DOI: 10.15413/ajmp.2018.0134 ISSN 2315-7720 ©2018 Academia Publishing Research Paper Investigation of antimicrobial activity and chemical constituents of Momordica charantia L. var. abbreviata Ser Accepted 17th July, 2018 ABSTRACT The antimicrobial potential of the four extracts of Momordica charantia L. var. abbreviata Ser., including n-hexane, chloroform, ethyl acetate and methanol- water 80:20 (v/v) extracts was screened against four bacterial and four fungal Nguyen PD.1, Vo MD.1, Luong HVT.1, Phan strains, using microbroth dilution assay. The chloroform extract showed the TTH.2 and Nguyen TTT.3* highest growth inhibitory activity with MIC = 200 μg/ml on both Escherichia coli and Bacillus subtillis and MIC = 100 μg/ml on Aspergillus niger. Phytochemical 1Faculty of Education, Can Tho University, Can Tho, Vietnam. study on the bioactive chloroform extract led to the isolation of four known 2Faculty of Science, Mien Tay compounds as octadecan-1-ol (1), (23E)-5β, 19-epoxycucurbita-6, 23, 25-trien- Construction University, Vinh Long, 3β-ol (2), 5α-poriferasta-7,25-dien-3β-ol (3) and 3-O-(6′-O-palmitoyl-β-D- Vietnam. glucopyranosyl)-clerosterol (4). Their structures were elucidated by 3Faculty of Science, Can Tho University of Medicine and Pharmacy, Can Tho, spectroscopic methods including 1D and 2D-NMR, MS and in comparison with Vietnam. literature data. Here, such metabolites were reported for the first time in M. charantia L. var. abbreviata Ser. *Corresponding author. E-mail: [email protected]. Tel: (+84)919886682. Key words: Antibacterial, antifungal, clerosterol, Cucurbitaceae, Momordica charantia.
    [Show full text]